Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Personal Products Industry Analysis

UpdatedApr 01, 2026
DataAggregated Company Financials
Companies114
  • 7D-0.5%
  • 3M-16.3%
  • 1Y-20.7%
  • YTDn/a

Last week, the Personal Products industry hasn't moved much but Olaplex Holdings is up 56% in that time. As for the longer term, the industry has declined 21% in the last year. Earnings are forecast to grow by 29% annually.

Industry Valuation and Performance

Has the U.S. Personal Products Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 02 Apr 2026US$73.4bUS$48.2bUS$670.2m20.9x109.5x1.5x
Sat, 28 Feb 2026US$96.2bUS$48.2bUS$839.5m21x114.6x2x
Mon, 26 Jan 2026US$97.2bUS$47.6bUS$350.1m22.8x277.5x2x
Wed, 24 Dec 2025US$90.9bUS$47.6bUS$351.4m22.7x258.5x1.9x
Fri, 21 Nov 2025US$79.8bUS$47.6bUS$558.0m21.6x143x1.7x
Sun, 19 Oct 2025US$91.3bUS$47.7bUS$307.9m20.2x296.5x1.9x
Tue, 16 Sep 2025US$94.1bUS$47.6bUS$304.0m21.4x309.4x2x
Thu, 14 Aug 2025US$101.7bUS$48.1bUS$562.2m21x180.9x2.1x
Sat, 12 Jul 2025US$99.1bUS$48.0bUS$109.5m17.8x905.6x2.1x
Mon, 09 Jun 2025US$94.7bUS$48.0bUS$127.3m17.2x743.8x2x
Wed, 07 May 2025US$90.5bUS$48.3bUS$375.0m21.9x241.3x1.9x
Fri, 04 Apr 2025US$93.2bUS$48.7bUS$556.6m22.7x167.5x1.9x
Sun, 02 Mar 2025US$95.4bUS$49.0bUS$328.5m26.9x290.4x1.9x
Tue, 28 Jan 2025US$98.5bUS$49.3bUS$1.5b26.1x66.8x2x
Thu, 26 Dec 2024US$98.5bUS$49.3bUS$1.5b27.8x66.7x2x
Sat, 23 Nov 2024US$100.3bUS$49.3bUS$1.5b28.5x68.1x2x
Mon, 21 Oct 2024US$103.5bUS$49.5bUS$1.6b26.7x64x2.1x
Wed, 18 Sep 2024US$107.3bUS$49.5bUS$1.6b21.8x65.5x2.2x
Fri, 16 Aug 2024US$106.9bUS$49.2bUS$2.0b18x54x2.2x
Sun, 14 Jul 2024US$111.6bUS$49.0bUS$2.4b21.5x46.1x2.3x
Tue, 11 Jun 2024US$113.0bUS$49.0bUS$2.4b23.3x46.6x2.3x
Thu, 09 May 2024US$120.1bUS$48.9bUS$2.5b24.8x49x2.5x
Sat, 06 Apr 2024US$126.0bUS$48.8bUS$2.5b25.8x49.7x2.6x
Mon, 04 Mar 2024US$130.4bUS$49.0bUS$2.5b30.4x53x2.7x
Wed, 31 Jan 2024US$127.7bUS$50.1bUS$2.6b27.1x50.1x2.5x
Fri, 29 Dec 2023US$129.7bUS$49.9bUS$2.6b23.9x49.3x2.6x
Sun, 26 Nov 2023US$114.8bUS$49.9bUS$2.6b24x44.1x2.3x
Tue, 24 Oct 2023US$115.8bUS$50.0bUS$3.3b23.6x35.4x2.3x
Thu, 21 Sep 2023US$126.9bUS$50.0bUS$3.3b23.5x38.6x2.5x
Sat, 19 Aug 2023US$134.8bUS$49.8bUS$3.0b21.2x44.3x2.7x
Mon, 17 Jul 2023US$150.3bUS$49.3bUS$3.1b22x47.9x3x
Wed, 14 Jun 2023US$147.0bUS$49.3bUS$3.1b21.6x46.9x3x
Fri, 12 May 2023US$153.0bUS$48.9bUS$3.3b19.3x46.7x3.1x
Sun, 09 Apr 2023US$118.9bUS$34.5bUS$1.7b17.7x70.9x3.4x
Price to Earnings Ratio

70.9x


Total Market Cap: US$118.9bTotal Earnings: US$1.7bTotal Revenue: US$34.5bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Personal Products Industry Price to Earnings3Y Average 167.8x202420252026
Current Industry PE
  • Investors are pessimistic on the American Personal Products industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 110x which is lower than its 3-year average PE of 168x.
  • The 3-year average PS ratio of 2.3x is higher than the industry's current PS ratio of 1.5x.
Past Earnings Growth
  • The earnings for companies in the Personal Products industry have declined 26% per year over the last three years.
  • Meanwhile revenues for these companies have grown 12% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does U.S. Personal Products compare with similar industries?

US Market-0.61%
Consumer Staples1.40%
Personal Products-0.53%
Personal Products-0.53%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
OLPX Olaplex HoldingsUS$2.0356.2%
+US$493.4m		57.4%PS3.2x
EL Estée Lauder CompaniesUS$71.770.4%
+US$104.9m		5.7%PS1.8x
EPC Edgewell Personal CareUS$21.348.8%
+US$80.8m		-31.6%PE158.2x
BRBR BellRing BrandsUS$16.091.3%
+US$24.6m		-78.6%PE10.3x
IPAR InterparfumsUS$90.840.8%
+US$22.8m		-20.3%PE17.3x

Latest News

HLF
US$14.72
Herbalife
7D
0.4%
1Y
67.1%
ELF
US$60.61
e.l.f. Beauty
7D
-10.3%
1Y
-5.7%

ELF: Market Share Gains And Raised Sales Outlook Will Support Upside

Analysts have trimmed their average price target on e.l.f. Beauty by about $2. This reflects updated views on slightly softer revenue growth and profit margins, partly offset by a higher assumed future P/E multiple and ongoing mixed signals in recent sales and consumption data.
COTY
US$2.01
Coty
7D
-2.4%
1Y
-63.6%
FTLF
US$14.20
FitLife Brands
7D
10.9%
1Y
19.8%
EPC
US$21.34
Edgewell Personal Care
7D
8.8%
1Y
-31.6%

EPC: Margin Improvement And Revised EPS Outlook Will Drive Attractive Returns

Analysts have modestly adjusted their price target on Edgewell Personal Care to $24.33. The revised target reflects updated assumptions around the discount rate, revenue trajectory, profit margins, and future P/E expectations.
EL
US$71.77
Estée Lauder Companies
7D
0.4%
1Y
5.7%

EL: Potential Puig Deal And New Fragrance Launch Will Support Future Upside

Analysts have trimmed their price targets for Estée Lauder Companies to around $106, reflecting slightly softer revenue growth assumptions, a marginally higher discount rate and a somewhat lower future P/E multiple, partly balanced by modestly stronger profit margin expectations. What's in the News Estée Lauder and Spanish beauty group Puig confirmed on March 23, 2026 that they are in discussions over a potential business combination that could create a company valued at more than US$40b, with no final agreement in place and no assurance that a transaction will occur (company statements, FT report).
KVUE
US$17.24
Kenvue
7D
-1.8%
1Y
-27.8%
IPAR
US$90.84
Interparfums
7D
0.8%
1Y
-20.3%

IPAR: Asset Light Model Will Benefit From New Long Term Fragrance Licenses

Analysts lifted their price target on Interparfums to $111.20 per share, supported by updated assumptions for a slightly lower discount rate, consistent revenue growth of 6.12%, stable profit margin of 11.19%, and a refined future P/E of 21.28x. Analyst Commentary Bullish Takeaways Bullish analysts see the refined future P/E of 21.28x as consistent with the company’s earnings profile, given the working assumptions around revenue growth and margins, rather than stretched for the sector.
SKIN
US$0.89
Beauty Health
7D
-19.1%
1Y
-27.6%
OLPX
US$2.03
Olaplex Holdings
7D
56.2%
1Y
57.4%
USNA
US$17.47
USANA Health Sciences
7D
2.7%
1Y
-35.9%

USNA: CEO Return And Costco Distribution Expansion Will Support Future Upside

Analysts have made only a minimal adjustment to their fair value estimate for USANA Health Sciences, keeping it effectively unchanged at about $39.00. Small tweaks to the discount rate, revenue growth, profit margin, and future P/E assumptions offset each other.
WALD
US$0.95
Waldencast
7D
-16.0%
1Y
-68.0%
NAGE
US$4.41
Niagen Bioscience
7D
-2.9%
1Y
-35.8%

NAGE: Core Demand And Injectables Will Support Future Upside Potential

Analysts have trimmed their price target on Niagen Bioscience to $13 from $14. This reflects updated models after Q4 results that pointed to steady demand in the core business and potential upside from the injectable segment.
BRBR
US$16.09
BellRing Brands
7D
1.3%
1Y
-78.6%

BRBR: Protein Adoption And Reset Expectations Will Shape Future Upside Potential

BellRing Brands' fair value estimate has shifted from $50.00 to $35.00 as analysts recalibrate price targets across the group, citing softer recent volume data, a reset in assumed future P/E multiples, and a more measured stance on competition, even as they still point to growing mainstream demand for convenient protein shakes and snacks. Analyst Commentary Recent Street research on BellRing Brands points to a mixed but still constructive backdrop, with several bullish analysts highlighting the broader protein theme and the company's role in it, even as price targets reset lower.
ODD
US$13.38
Oddity Tech
7D
-3.2%
1Y
-70.3%

ODD: Advertising Algorithm Reset Will Eventually Restore Customer Acquisition Efficiency

Analysts have sharply reduced the consolidated price target for Oddity Tech to about $29.17 from $90, reflecting concerns around higher customer acquisition costs, weaker visibility after the recent ad platform disruptions, and more conservative assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Street research has shifted sharply more cautious on Oddity Tech, with multiple firms cutting price targets and moving ratings to more neutral or negative stances.
YSG
US$3.08
Yatsen Holding
7D
-6.7%
1Y
-34.6%

YSG: Convertible Notes And Revenue Outlook Will Support Earnings Recovery

Analysts have lifted their price target on Yatsen Holding from $7.14 to $7.54, reflecting updated assumptions around fair value, discount rate, revenue growth, profit margin, and forward P/E that they see as better aligning the stock with its current risk and earnings profile. What's in the News Yatsen Holding plans a private placement of Senior Convertible Notes totaling US$120,000,000, paired with warrants to purchase Class A ordinary shares, under a purchase agreement dated March 11, 2026 (Key Developments).